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Purpose: The purpose of this study was to evaluate the outcomes of our 6-year experience 
with directional atherectomy used for treatment of stenoses in infrainguinal vein grafts. 
Methods: From March 1988 to April 1994, 52 directional atherectomy procedures were 
undertaken i  42 patients to treat 67 stenoses in 44 vein grafts. Follow-up consisted of 
periodic physical examinations and graft surveillance: ankle/brachial indexes, pulse 
volume recordings, and color-flow duplex ultrasonography. Follow-up angiography 
(n = 18) was performed for recurrent symptoms, reproducible drop in ankle/brachial 
index of greater than 0.15, a twofold to threefold focal increase in peak systolic velocity, 
or incidentally during evaluation of the opposite leg. 
Results: Forty-nine of 52 (94%) procedures were technically successful. In two the residual 
diameter stenosis was greater than 30%, and in one atherectomy could not be performed. 
Complications were minor in six (11%) and major in three (6%): two acute graft occlusions 
and one delayed pseudoaneurysm at the atherectomy site. There were no deaths at 30 days. 
With a mean follow-up of 21 + 18 months, 36 of 44 grafts (82% ) remained patent without 
restenosis; 6 others were patent but considered "failed"--5 (11%) with restenosis, 1 with 
a pseudoaneurysm; and 2 grafts (5%) occluded. Clinically 33 of 44 extremities (75%) were 
asymptomatic during follow-up. Claudication improved in five, recurred in three, and was 
unchanged in one. There was one below-knee amputation. Life-table analysis including all 
52 procedures reveals cumulative primary atherectomy patency rates for the 44 grafts of 
82%, 78%, and 78%, respectively, at1, 2, and 3 years after atherectomy, and 86%, 83%, and 
83% for the 67 individual stenoses treated. 
Conclusions: Directional atherectomy ofvein graft stenoses has high technical and clinical 
success rates, acceptably low morbidity rates, and offers better sustained patency rates than 
balloon angioplasty. Its long-term patency rate seems to approach that of surgical vein 
patch angioplasty. (J VASC SURG 1996:23:554-67.) 
Since its clinical introduction in 1987, directional 
athcrectomy with the Simpson Peripheral Atherocath 
or Athcrotrack (Devices for Vascular Intervention, 
Inc., Redwood City, CaliE) has been used with 
increasing frequency t~br treatment of stenoses and 
short occlusions in the iliac and femoropopliteal 
arteries.~ 6 It was postulated that this atherectomy 
device's actual removal ofatheroma might result in a 
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lower restcnosis rate compared with the more trau- 
matic remodeling of the atheroma nd arterial wall 
during percutaneous transluminal balloon angio- 
plasty (PTA). 79 
Stenoses in int?ainguinal vein bypass grafts can bc 
difficult to dilate by PTA, often requiring high- 
pressure balloons and prolonged inflation times, and 
are associated with disappointing long-term patency 
rates.~0 ~2 We postulated that these hyperplastic and 
fibrotic stenoses might respond better to resection by 
directional atherectomy (DA), thus, it was hoped, 
lowering rcstenosis rates and prolonging graft pa- 
tency. Thus we have performed DA to treat most 
lower extremity vein graft stenoses at our hospital 
since 1988. The purpose of this study was to evaluate 
the technical success, clinical outcome, and graft 
patency achicved by DA of vein graft stcnoses, and to 
compare these results with the published ata on PTA 
and surgical repair. 
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Table I. Relationship of 44 grafts, 52 procedures and 67 stenoses 
No. of graft stenoses 
treated per procedure 44grafts No. of grafts x No. of procedures per graft 52procedures 6 7 stenoses 
28 • 1 
1 33 4* x 2 39 39 
1 t x 3 
2 9 7 x 1 l l  22 
2~ x 2 
3 __2 2 x 1 2 6 
44 52 67 
*Three grafts with single DA restenosis and one graft with a new stenosis. 
tOne graR with two new nonsynchronous stcnoses. 
:~Two grafts with two new synchronous stenoses. 
MATERIAL AND METHODS 
Between March 1988 and April 1994, we at- 
tempted 52 atherectomy procedures and were able to 
perform 51--treating 66 of 67 stenoses in 43 of 44 
infrainguinal vein grafts in 41 of 42 patients. Eleven 
grafts had more than one graft stenosis treated uring 
the same procedure, and seven grafts had more than 
one DA procedure during the 6-year interval (Table 
I). However, primary atherectomy patency fbr each 
graft was based on the results of its initial DA 
procedure only. The fbllow-up intcrval includes data 
available through November 1994. 
Patients. Demographic and clinical data for the 
42 patients are listed in Table II, A. Half werc 
symptom free at the time of atherectomy, with their 
stenoses discovered uring routine noninvasive fol- 
low-up. 
Vein grafts. Characteristics of the 44 vein grafts 
are outlined in Tables II, Band II, C. Half(n = 22) of 
the gratis were placed at the poplitcal artery and half 
more distally. Most were in situ saphenous (n = 23) or 
composite (n = 15) vein grafts. At the time ofatherec- 
tomy, 31 of 44 vein grafts had a mean primary patency 
of 13 months (1 to 96). The other 13 had undergone 
various revisions and presented with a mean second- 
ary patency of 23 months (3 to 76) before atherec- 
tomy. At the time of atherectomy, all grafts were 
patent, with one or more stenoses. 
Stenoses. Features of the 67 stenoses are shown in 
Table II, D. Most of the stenoses were short (mean 
1.1 cm) and moderate to severe in nature (mean 81% 
diameter stenosis). Intragraf~ lesions (n = 39) slightly 
outnumbered those at anastomoses (n = 28). Arterial 
stenoses just beyond the anastomosis (n = 6) treated 
concurrently, such as those resulting from clamp 
injuries or progression of native disease, were not 
included as anastomotic graft stcnoses in this analysis. 
Atherectomy procedure. The. patients received 
10 mg sublingual nifedipine just befbre direct ante- 
grade puncturc of thc vcin graR in the upper thigh. 
Alter graft angiography with a 4F or SF diagnostic 
catheter, a 6F to 9F vascular introducer sheath corre- 
sponding to the size of the atherectomy catheter 
chosen was inserted by use of the Seldinger technique. 
Heparin, 3000 to 5000 units, was then given intra- 
venously. Multiple 200 gg boluses of nitroglycerin 
were administered through the sheath directly into 
the vein graft during the course of the procedure. 
Heparin was not continued after atherectomy when 
the procedure was uncomplicated. In three proce- 
dures, 6F atherectomy catheters were used, 7F in 41, 
and 9F in eight. Digital road mapping, with contrast 
injected via the side arm of the introducer sheath, was 
used to guide and position the atherectomy catheter 
across the stenosis. 
The basic mechanics and technique of directional 
athcrcctomy have bccn well described elsewhere) ,~3 
In attempt o rcscct as much of  the stcnosis as we 
could, 9'14 multiple cuts were performed with the 
cutter rcpositioncd stcp-by-step, under fluoroscopic 
guidance, around the entire circumtkrencc ofthe vein 
lumen. This sequential process was then repeated for 
a total of two to three complete rotations for each 
stcnosis, with fbur to five cutting positions over each 
360 degrees. Procedure ndpoint was determined by 
completion angiography in multiple projections, with 
a residual diameter stenosis of 30% or less considered 
acceptable. However, wc attempted to achieve a 
residual stcnosis less than 10% whcncvcr possible. 
Athcrcctomy alone, without PTA, was used for 41 
of 52 graft procedures. Atherectomy was performed 
during the same procedure at the same site after 
technically unsuccessful PTA in 8 of 52, whereas PTA 
was pcrformcd to supplement technically unsucccss- 
fhl DA in 2 of 52. In one, DA could not be performed. 
Additionally, nine of 52 procedures also involved 
concurrent treatment of inflow (two PTA, one DA) or 
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Table II, A. Patient characteristics (n = 42) 
Demographics (n= 42 patients) 
Sex (men/women) 28/14 
Mean age (yrs.) 72 -+ 8 (range 53-86) 
Diabetes 10 (24%) 
CAD/CVA 19 (45%) 
Hypertension 23 (55%) 
Smoking 25 (60%) 
Presentation ( = 52 limbs)* 
Symptoms 26 (50%) 
Claudication 20 
Nonhealing ulccrs 5 
Rest pain 1 
Without symptoms 26 (50%) 
Positive noninvasives 
CAD, Coronary artcry disease; CVA, cerebrovascular ccident. 
*At time of atherectomy. 
Table II, B. Graft characteristics (n = 44) 
No. (%) 
Level 
Femoropopliteal 22 50% 
Above-knee 10 
Below-knee 12 
Femorotibial 22 50% 
Material 
In situ saphenous 23 52% 
Nonreversed, exsitu saphenous 4 9% 
Reversed saphenous 2 5% 
Composite 15 34% 
Distal runoff 
No. vessel runoff 
<1 4 9% 
1 23 52% 
2 13 30% 
3 4 9% 
outflow (three PTA, three DA) perianastomotic 
stenoses in the patient's native arterial circulations. 
Postatherectomy graft surveillance. Patients 
were maintained on 325 mg aspirin daily, except for 
12 patients who were already receiving warfarin 
(Coumadin). Six weeks after DA, and every 3 months 
for the first year, then every 3 to 6 months thereafter, 
the patients were evaluated by careful vascular history 
and physical examination, ankle/brachial index (ABI) 
with pulse volume recordings, and color-flow duplex 
ultrasonography (CDS). Four of the 42 patients 
(10%) died at a mean of 25 months (8 to 58) during 
the follow-up interval, and 7 were lost to follow-up. 
Follow-up graft angiography was performed fbr 
recurrent symptoms, a sustained rop in ABI, focal 
increase in peak systolic velocity, or incidentally dur- 
ing angiography of the opposite leg. Eighteen grafts 
were restudied angiographically at a mean of 12 
months (range 2 to 36) after DA. Final determination 
of the presence or absence of restenosis during the 
Table II, C. Graft patency, preatherectomy 
(,I = 44) 
Mean Range 
(mos.) (mos.) 
Primary patency (n = 31 ) 13 1-96 
Secondary patcncy (n = 13) 23 3-76 
Table II, D. Stenosis characteristics (n = 67) 
No. (%) 
Location 
Anastomotic 
Proximal 
Venovcnous 
Distal 
Intragraft 
Length 
<1 cm 
1-2 cm 
>2 cm 
Severity (% lumen diameter) 
>85% 
70%-85% 
50%-70% 
2 
9 
17 
28 42% 
39 58% 
38 57% 
23 34% 
6 9% 
32 48% 
30 45% 
5 7% 
follow-up interval was made by CDS (twofold to 
threefold fbcal increase in peak systolic velocity) in 33 
and by angiography ( > 50% diameter stenosis) in 18 of 
the 51 atherectomies actually performed. 
Analysis. Results were analyzed in two groups. 
The DA/PTA group included all 67 stenoses in all 44 
grafts treated by DA, whether alone or in combination 
with graft PTA. The DA-only subgroup was com- 
prised of those for which only DA was performed, 
without PTA (57 stenoses in 35 grafts). Results were 
evaluated by use of the life-table method, as detailed 
by the Ad Hoc Committee on Reporting Standards, 
Society for Vascular Surgery/International Socieq, 
for Cardiovascular Surgery, North American Chap 
ter, 1"~ and are reported according to recent publica- 
tions detailing common reporting standards. ~6a7 
Life-tables were compared for significant differences 
by use of the log-rank test. 
RESULTS 
Technical success, defined as 30% or less residual 
diameter stenosis angiographically, was achieved in 49 
of 52 procedures (94%), for 64 of 67 stenoses (95%). 
Residual stcnosis less than 10% was attained in 43 of 
67 (64%) (Tables III, A). The mean diameter stenosis 
was 81% (range 50% to 99%) before athercctomy and 
11% after atherectomy (range 0% to 30%). There 
were three technical failures. The first failure repre- 
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Table I I I ,  A. Procedure/site outcomes: 
DA/PTA group--technical success (<30% 
residual stenosis) 
Technical success No. (%) 
Procedures (n = 52) 49 94% 
Sites (n = 67) 64 95% 
% Diameter stenosis 
Before DA (n = 67) 
>85% 32 48% 
70%-85% 30 45% 
50%-70% 5 7% 
After DA (n = 67) 
<10% 43 64% 
10%-30% 21 31% 
>30 3 5% 
Table I I I ,  B. Procedure/site outcomes: 
DA/PTA group---complications 
Complications in 52 procedures No. (%) 
Overall 9 17% 
Minor 6 11% 
Small hematomas 4 
Small silent thromboemboli 2 
Major 3 6% 
Early graft thromboses 2 
Late pseudoaneurysm at DA site 1 
Table I I I ,  C. Clinical outcomes: 
DA/PTA group--primary atherectomy patency 
Primary atherectomy 
patency 67 stenoses 44grafts 
Patent 57 (85%) 36 (82%) 
Failed 10 (15%) 8 (18%) 
Restenosis 7 (10%) 5 (11%) 
Pseudoaneurysm 1 1 
Occlusion 2 2 
sented the one graft in which we were not able to 
perform DA. A 9F sheath could not be placed 
through extensive scar tissue into this 8-year-old 
reversed saphenous vein graft. The two other failures 
occurred in grafts with focal stenoses that were 
debulked and improved considerably by atherectomy, 
but a thin persistent eccentric weblike area in the 
stenotic segment in both grafts could not be elimi- 
nated, and therefore supplemental PTA was per- 
formed, successfully in both instances. 
Overall, complications occurred in nine of 52 
procedures (17%) (Table III, B). Six were minor 
(11%), consisting of four small puncture-site hemato- 
mas and two small subclinical, nonocclusive throm- 
boemboli. The latter two were successfully treated 
Table I I I ,  D. Clinical outcomes: DA/PTA 
group--leg symptoms (n = 44 legs) 
No. (%) 
No symptoms 33 75% 
Claudication 9 20% 
Improved 5 
No change 1 
Recurrent 3 
Rest pain 2 5% 
Acute 1 
No change 1 
Table IV, A. Additional graft revisions after 
the initial DA of each graft (n = 15 revisions 
in 14 grafts) 
Interventions 
Indications No. DA PTA Surgery 
DA restenosis 5 3* 1 11" 
DA pseudoaneurysm 1 - -  - -  1 :[z 
DA occlusion 2 - -  - -  1 w 
New stenosis 7 5 2 111 
Total 8 3 4 
*Repeat DA. 
1"Jump graft and VPA. 
J~Interposition graft. 
w and prosthesis. 
IIThrombectomy and VPA. 
Table IV, B. Extended patency of additional 
graft revisions after the initial DA of each graft 
(n = 15 revisions in 14 grafts) 
DA PTA Surgery 
(n =8) (n =3) (n =4) 
Patent 7 (5,6,8,12,15,32,46) 1 (1) - -  
Restenosis 1 (4) - -  1 (12) 
Occluded - -  2 (1,7) 3 (0,4,5) 
Numbers in parentheses indicate months after revision. 
with 250,000 units urokinase administered over 1 
hour, with continuation of intravenous administra- 
tion ofheparin for 24 hours. There were no puncture- 
site pseudoaneurysms or stenoses. There were no 
deaths at 30 days. 
Three of the complications were major (6%). 
There were two early graft occlusions. One occurred 
in a diffusely small (2 mm) 2-month-old femorotibial 
vein graft with preocclusive Doppler signals and a 
tight stenosis causing angiographic "pseudoocclu- 
sion." The graft occluded 2 days after technically 
successful atherectomy was performed immediately 
after unsuccessful graft PTA as an attempt at limb 
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Table V. Comparison of primary atherectomy patency rates: all procedures combined versus those 
performed with DA only 
Procedure treatment group 
Cumulative % patenc~ rate by life-table analysis 
No. l yr 2yr. 3yr. 
DA/PTA* 
Stenosis ites 67 86% 83% 83% 
Grafts 44 82% 78% 78% 
DA only'i" 
Stenosis ites 57 87% 84% 84% 
Grafts 35 84% 79% 79% 
*n = 52 procedures (42 DA only; 10 PTA and DA). 
l"n = 42 procedures. 
Table VI, A. Comparison of primary patency rates for VPA and atherectomy 
Patency rate 
Dates of study No. of grafts 1 yr. 3 yr. 5 yr. 
Vein patch angioplasty (literature) 
Whitternore etal. al 1969-1979 8 grafts* 86% -- 86% 
Cohen et al. 2~ 1980-1985 22 grafts* 85% -- 82% 
Vein graft atherectomy 
BIH 1988-1994 35 grafts{ 84% 79% -- 
BIH, Beth Israel Hospital. 
* Revised patent. 
"~Revised patent by atherectomy only (no PTA). 
salvage. This patient required a subsequent below- 
knee amputation, and currently ambulates actively on 
his prosthesis. The other occlusion occurred in the 
graft that could not be accessed with a 9F sheath to 
perfbrm atherectomy. Prolonged attempts to dilate 
the extensive scar tissue at the graft puncture site, over 
a heavy-duty guide wire lying within a relatively static 
blood column in this graft with a tight distal stenosis, 
resulted in acute graft thrombosis in the angiography 
suite. This required urgent operation fbr graft throm- 
bectomy and vein patch angioplasty (VPA). This 
revised graft reoccluded 4 months later. One 
pseudoaneurysm developed at the atherectomy site in 
the mid graft 3 months after the procedure. This was 
repaired with an interposition vein graft. Unfortu- 
nately the graft developed aggressive, diffuse intimal 
hyperplasia and occluded 5 months later. 
The atherectomy shavings specimens from the 
first 11 procedures were submitted for histologic 
analysis. The predominant pathology was intimal 
hyperplasia, seen in all 11, with additional mixed 
atherosclerotic elements in two. Nine of the 11 
specimens contained elements of media, and 7 of 11 
contained fi'agments of graft adventitia. Two had 
additional small fragments of thrombus, and one 
contained a small fragment of surgical suture. The 
resected suture was not associated with extravasation 
of contrast at the distal anastomosis atherectomy site 
on completion angiography, and no pseudoaneurysm 
was detected by CDS during a 19-month follow-up 
interval. 
Primary atherectomy patency (AP) was defined as 
a patent graft  without evidence of restenosis or new 
stenosis by either CDS or angiography. I fa graft devel- 
oped a new stenosis elsewhere in the graft, or a 
restenosis or pseudoaneurysm at any one of its 
atherectomy sites, its primary AP ended. Revised 
patency resulting from three repeat DAs for re- 
stenoses in three grafts, or from five additional DAs 
for new stenoses in tour grafts, was considered pri- 
mary assisted AP. 
During a mean follow-up of 21 + 18 months 
(range 0 to 74), we noted a site-specific primary AP of 
85% (57 of 67) tbr stenoses, and an overall primary AP 
of 82% (36 of 44) for grafts, in the combined 
DA/PTA procedure group (Table III, D). Thirty- 
three of 44 lower extremities (75%) were asymptom- 
atic during follow-up. Nine of 44 (20%) experienced 
claudication: improved in five, unchanged inone, and 
recurrent in three. One leg with acute graft occlusion 
had no change in rest pain and nonhealing ulcers 
before a below-knee amputation and prosthesis, 
which have restored activity. This patient also had 
development of three nonsynchronous stenoses in a 
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Table VI, B. Comparison ofrestenosis and occlusion rates for VPA and atherectomy 
Range 
Dates of study No. of procedures (mos.) 
Failure 
Restenosis Occlusion 
rate rate 
Vein patch angioplasty (literature) 
Bandyk et al. 2"~ 
Vein graft atherectomy (BIH) 
BIH 
1982-1990 31 VPAs* 3-72 
1988-1994 57 stenoses~ 0-66 
23% 3% 
11% 2% 
BIH, Beth Israel Hospital. 
* Revised patent. 
"i'Rcviscd patent by athcrcctomy only (no PTA). 
fcmorotibial vcin graft in his othcr lcg, each treated 
with DA. These have all remained patent without 
restenosis or symptoms. 
In the DA-only treatment subgroup, there were 
similar primary APs of 86% (49 of 57) for stenoses and 
83% (29 of 35) for grafts. The other 6 of 35 grafts 
(17%) wcrc categorized as primary athcrcctomy thil- 
ures. As detailed above, one occluded acutely during 
attempted access tbr atherectomy, and one developed 
a pseudoancurysm. Four of 35 (11%) incurred rcste- 
nosis at a mean of 9 + 6 months after atherectomy. 
One of these four restenoses was treated by PTA 
alone, but this graft occluded 7 months later. The 
other three rcstcnoses were treated by repeat athcrec- 
tomy, and all three of these grafts have remained 
patent without recurrent stenosis on further fbl- 
low-up ranging from 5 to 46 months after their 
respective revisions. Two of 35 grafts developed new 
stenoses, treated by DA only. One graft remained 
patent 15 months after its second athcrcctomy. Rc- 
stenosis occurred in the other graft 4 months later. 
Thus there was an 89% (31 of 35) primary assisted 
DA-only graft patency rate. In the combined 
DA/PTA group, there were seven additional patent 
grafts, one other restenosis (treated by jump 
graft + VPA), and one other acute occlusion. There 
was an overall 86% (38 of 44) primary assisted graft 
patency in the combined DA/PTA group. Further 
graft revisions and extended patcncy rates arc detailed 
in Tables IV, A and B. 
Life-table analysis 
By life-table methods for the DA-only subgroup, 
there was a cumulative primary atherectomy graft 
patcncy rate of 84% at 1 year and 79% at 2 and 3 years, 
with corresponding stenosis/site patency rates of 87% 
and 84% (Fig. 1). Although the overall numbers in 
this series arc relatively small, patency outcomes 
(Table V) did not differ significantly whether the 
"pure" DA-only subgroup of 35 grafts was analyzed 
alone or in combination with the "mixed" DA/PTA 
treatment of the nine other grafts. Log-rank tests 
failed to show any statistically significant differences 
(p < 0.05) between technical success or cumulative 
patcncy rates for patient parameters of sex, diabctcs, 
history of  smoking, leg symptoms, or aspirin versus 
Coumadin therapy; graft parameters of  femo- 
ropopliteal versus fkmorotibial location, in situ saphe- 
nous versus composite veins, or number of  run-off 
vessels; and stenosis parameters of  length, anasto- 
motic versus intragraft location, or multiple versus 
single stcnoscs trcatcd per procedure. 
In the subset of 24 grafts that had never bccn 
revised before atherectomy and that were treated with 
DA only, without PTA, there were cumulative pri- 
mary assisted graft patency rates of 96% at 1 year, 91% 
at 2 years, and 82% at 3 years, with a trend for patency 
maintained at this level in later years. Atherectomy 
extended the patency rates of these 24 grafts from a 
mean primary patency of 13 months to a mean 
assisted primary graft patency of 32 months. 
DISCUSSION 
Close surveillance of patients with lower extremity 
venous bypass grafts, especially during the first 2 years, 
by noninvasive testing with ABI, pulse volume re- 
cording, and, most importantly, CDS has become 
standard management. ~8,19 These can detect he de- 
velopment of significant stenoses within the graft or at 
the anastomoses. Early dctection allows timely repair 
before the stcnosis has progressed to graft thrombo- 
sis. Once graft thrombosis occurs, thrombolysis or 
surgical thrombcctomy and repair carry higher mor- 
bidity rates and have dismal ong-term patency rates 
compared with semielective surgical repair/revision 
of a patent graft with a stenotic segment. 2~ 
Balloon PTA has been used to treat vein graft 
stenoses. In some centers PTA has been used as the 
first approach to these lesions because it is considered 
less invasive, less costly, and more easily repeatable 
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Fig. 1. A, Primary atherectomy site patency, 57 stenoses 
(DA only). B, Primary atherectomy graft patency, 35 grafts 
(DA only). 
than surgical revision. TM12'22 Thc literature on PTA of 
vein graft stenoses consists of nonstandardized re- 
ports, which are difficult o compare and which show 
a wide variation of patency rates. Whereas most PTA 
series report a high (approximately 95%) initial tech- 
nical success rate and low morbidity rate, 1~176 the 
long-term graft patency rate results after PTA in the 
larger series are disappointing, varying from 39% to 
57% at 1 year to 22% to 39% at 2 years. 2s 2s Although 
we do not have matched controls tbr comparison, the 
cumulative primary AP rate of 84% at 1 year and 79% 
at 2 and 3 years, with corresponding individual 
stenosis/site patency rates of  87% and 84%, present in 
the DA-only subgroup of this series are encouraging. 
These have prompted us to continue to use DA 
instead of PTA or surgical repair as the first treatment 
tbr vein graft stenoses whenever possible. 
The other advantages of atherectomy compared 
with PTA, besides improved long-term patency rates, 
include the removal of the fibrotic/hyperplastic le- 
sion, a lower incidence of  dissection or graft rup- 
ture, 8'9'29'3~ and the ability to salvage PTA failures. 
The disadvantages ofatherectomy are that it is a more 
complex and tedious procedure than balloon angio- 
plasty, asingle atherectomy catheter (-$1000) is more 
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Fig. 2. DA extended graft patency (solid boxes) 44 grafts 
(combined DA/PTA), and graft patency preatherectomy 
(open boxes). 
expensive than a balloon angioplasty catheter ($250 
to $325) if just one is used, and atherectomy is of 
limited use in narrow (2 to 3 mm) or acutely angu- 
lated vein grafts because of catheter size (smallest-- 
6F -- 2 ram) and rigidity of the metal cutter housing. 
However, because of  their shorter collection cham- 
bers, less rigid tips, and ability to be positioned over a 
guide wire, 6F coronary DA catheters (Atherocath 
G.T.O.; DVI/ACS, Redwood City, Calif.) have en- 
abled atherectomy to be performed in tortuous grafts 
and at very distal (dorsalis pedis or plantar) arterial 
anastomoses. 
Each stenosis/graft/patient is considered on a 
case-by-case basis. With our evolving experience, we 
now generally avoid using DA as our first modality in 
small-diameter (<3 mm) grafts, preferring to use PTA 
catheters less than 4F. For stenotic segments of 5 cm 
or greater in length, we usually opt for surgical repair 
with interposition or jump grafts. If the stenosis is less 
than 3 cm, surgical repair is generally not undertaken 
unless DA/PTA has failed (restenosis) twice. For 
stenoses between 3 to 5 cm, other factors (such as a 
patient's operative and anesthetic risks, available na- 
tive vein, and need for additional inflow/outflow 
procedures) play a significant role in deciding whether 
to perform initial percutaneous or operative repair. 
Vein graft patency rates after atherectomy seem to 
compare favorably with patency rates after surgical 
revision by VPA for short focal graft stenoses (Table 
VI, A). In a report by Whittemore t al.3~ in 1981, a 
subgroup of  eight stenotic femoropopliteal vein grafts 
revised while patent with patch angioplasty had a 
5-year primary VPA patency rate of 86%. In 1986, 
Cohen et al.20 reported an 82% 5-year patency rate for 
a subsequent group of 22 patent vein grafts with 
stenoses that were reconstructed with VPA, also 
performed at Brigham and Women's Hospital. In our 
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series, the 35 stenotic grafts revised while patent with 
DA only (no PTA) realized primary atherectomy 
patency rates of 84% at 1 year and 79% at 2 years, with 
a trend to sustain that level further (Fig. 1, B). 
In 1991, Bandyk et al. -'3 (Table VI, B) reported on 
the outcomes of 103 revisions in 83 patent vein grafts, 
which included 31 VPA. Seven (23%) of these 31 VPA 
restenosed, and one (3%) occluded. Among the 57 
stenoses we treated with DA only, there were eight 
f~lures (14%), including six (11%) with restenosis, 
one with a pseudoaneurysm at the atherectomy site, 
and one (2%,) occlusion--the one graft in which we 
were not able to pcrtbrm DA. In Bandyk's series, 
excision with primary repair and interposition grafts 
fared much better than VPA, whercas PTA and jump 
grafts were less eflkctive. 
The theoretical advantages of athcrcctomy com- 
pared with surgical repair include preservation of 
remaining intact native veins fbr subsequent opera- 
tions, short length of hospital stay (typically a same- 
day admission fbr combined angiography and 
atherectomy, with overnight observation and dis- 
charge the next day), and possibly lower overall 
morbidity rates and costs (from both surgery and 
anesthesia). However, these have not been evaluated 
in randomized or matchcd studies. Comparative 
analyses fbr f~:moropopliteal and coronary PTA versus 
their respective surgical bypass procedures have indi- 
cated overall cost advantages fbr the percutaneous 
procedures. 32,33 
Resection of fragments of media and adventitia 
during DA is common in our cxperience, as well as 
others. 7'~4,'v~ Fortunately, this is not associated with as 
frequent complications. DA has led to only one graft 
pseudoaneurysm at the atherectomy site in our series. 
One pseudoaneurysm has been reported at a popliteal 
artery athercctomy site. "~6 These experiences are in 
keeping with the low incidence of  f]alse aneurysms 
seen after operative thromboendarterectomy in 
which substantial portions of arterial media are re- 
moved routinely. That more pseudoaneurysms do not 
develop at DA and puncture sites in vein grafts may 
reflect a bolstering effect by the periadventitial 
reaction/scar that contributes to hemostasis and 
helps to contain angiographically and clinically unrec- 
ognized small graft perfbrations. 
Histologic evaluation of the DA-resected material 
from the one site that later developed the pseudoan- 
eurysm did reveal fragments of adventitia. However, 
even on retrospective r view, the amount ofadventitia 
and depth of the cuts did not appear emarkably more 
than was seen in specimens from other DA sites that 
did not develop a pseudoaneurysm. The immediate 
post-DA angiographic appearance of the site, how- 
ever, did differ from others in that it showed mild 
fusiform aneurysmal dilation and small focal areas of 
apparent contrast intravasation into the vein graft 
wall. We have seen this appearance before in a stenotic 
vein graft after unsuccessful overdilation by PTA. 
Although the contrast appeared to be in a dilated 
lumen, at surgical revision the vein graft was found to 
have a longitudinal tear at the PTA site with a 
contained graft rupture. Retrospectively we suspect 
that a similar'rupture occurred in our patient during 
the multiple atherectomy balloon inflations, extend- 
ing a tiny initial tear from a focus of deep wall 
resection. At surgery, a 4 cm-long pseudoaneurysm 
was seen as the only continuity between the normal 
vein graft segments above and below it. 
The surprise of a surgical suture with its knot in 
one of  our resected specimens has also been observed 
during peripheral 7 and coronary 3"~ atherectomy. 
There has been no pseudoaneurysm at this atherec- 
tomy site on multiple CDS studies over a 19-month 
fbllow-up interval. We suggest that the integrity of the 
surgical anastomosis was not threatened because the 
remaining suture was covered by biologic neointima 
from a native vein to a native artery anastomosis and 
buttressed by adjacent scar tissue. Anastomoses in- 
volving synthetic grafts may be at higher risk of 
dehiscence if the suture is cut. Therefbre we have used 
balloon angioplasty instead of atherectomy for syn- 
thetic graft anastomotic stenoses. However, two re- 
cent small series a7,38 of patients having directional 
atherectomy for synthetic graft anastomotic stenoses 
have reported encouraging results, without occur- 
rence of this theoretical complication. 
No puncture site pseudoaneurysms occurred in 
our series, despite the use of up to 9F introducer 
sheaths and intraprocedural dministration of  hep- 
arin. An ipsilateral antegrade approach is required 
because the metal cutter housing of the Simpson 
device will not cross the aortic bifurcation from a 
contralateral retrograde femoral approach. Direct 
antegrade puncture of the vein graft a9 in the upper 
thigh has several advantages over antegrade puncture 
of the ipsilateral common femoral artery. It avoids the 
technical difficulties presented by patients with pro- 
tuberant panniculus and does not risk suprainguinal 
puncture, with possible retroperitoneal bleeding. Es- 
pecially with in situ saphenous grafts, the vein is 
superficial and easily palpable and compressible. It
obviates difficult catheter and guide wire maneuvers, 
with limited purchase in the common femoral artery, 
often required to selectively enter the graft across the 
proximal anastomosis. The multiple bends and angles 
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that a 7F to 9F sheath must traverse from a common 
femoral artery approach can cause kinking and diffi- 
culties inserting the atherectomy device. 
In conclusion, we have found directional atherec- 
tomy treatment of focal stenoses in infrainguinal vein 
bypass grafts to have high initial technical success rates 
(94%), acceptable low major morbidity rates (6%), 
and favorable mid- and long-term patency rates (78% 
to 84%) (Table V). It results in better, more sustained 
patency rates than balloon angioplasty. Its long-term 
patency seems to approach that of surgical vein patch 
angioplasty (Table VI). As always, comparative ran- 
domized and cost-effectiveness tudies would be 
valuable. 
In everyday practice, one encounters a variety of 
stenoses in a wide range of patients who should each 
be considered individually, with both surgical and 
percutaneous techniques available for stand-alone or 
combined use, as appropriate. Comparison of the 
life-table cumulative patency curves for the grafts 
before atherectomy with their extended primary pa- 
tency resulting from atherectomy (Fig. 2) shows that 
atherectomy considerably improved and extended the 
patency of these failed grafts. Meanwhile, the dura- 
bility of the results carries substantial c inical benefit 
~br this group of patients. 
The meticulous noninvasive follow-up of these patients 
by Frances Sousa, RN RVT, Christine Rizzitano, RN RVT, 
and Toni Perry, CMA-AC, was invaluable for this study and 
is greatly appreciated. We also thank Roger Davis, ScD, fbr 
his help with statistical analysis and Linda Nelson for her 
assistance with manuscript reparation. 
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Appendix A. Primary atherectomy patcncy rate--67 stenoscs*: combined DA/PTA group 
No. Duration Interval Cumulative Standard 
Interval No. DA sites atherectomy of FlU Lost to Lost by patency patency error 
(too.) at risk failures Ends FlU death rate (%) (%) 
O- 1 67 2 0 0 0 0.97 1.00 0.0 
1-3 65 3 0 2 0 0.95 0.97 2.1 
4-6 60 3 6 0 0 0.95 0.92 3.3 
7-9 51 0 2 0 2 1.00 0.88 4.3 
10-12 47 1 6 3 0 0.98 0.88 4.5 
13-15 37 0 1 0 5 1.00 0.86 5.3 
16-18 31 1 1 1 0 0.97 0.86 5.8 
19-21 28 0 2 1 1 1.00 0.83 6.5 
22-24 24 0 1 0 0 1.00 0.83 7.0 
25-27 23 0 1 0 0 1.00 0.83 7.2 
28-30 22 0 4 0 0 1.00 0.83 7.3 
31-33 18 0 4 0 0 1.00 0.83 8.1 
34-36 14 0 2 0 0 1.00 0.83 9.2 
37-39 12 0 1 0 0 1.00 0.83 9.9 
40-42 11 0 0 1 0 1.00 0.83 10.4 
43-45 10 0 1 0 0 1.00 0.83 10.9 
46-48 9 0 4 0 2 1.00 0.83 11.5 
49-51 3 0 0 0 0 1.00 0.83 19.9 
52-54 3 0 0 0 0 1.00 0.83 19.9 
55-57 3 0 0 0 0 1.00 0.83 19.9 
58-60 3 0 0 0 0 1.00 0.83 19.9 
61-63 3 0 0 0 0 1.00 0.83 19.9 
64-66 3 0 2 0 0 ! .00 0.83 19.9 
67-69 1 0 0 0 0 1.00 0.83 34.4 
70-72 1 0 0 0 0 1.00 0.83 34.4 
73-75 1 O 1 0 0 1.00 0.83 34.4 
lOt 8 
FlU, Follow-up. 
*Fif~-seven stenoses treatcd by DA only; eight PTA failures (>30% residual stenosis) followed by DA; 2 DA thilures (>30% residual stcnosis) 
followed by PTA. 
tTwo occlusions at 0 to 1 month, one pseudoaneurysm at 3 months, and seven restenoses. 
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Append ix  B .  P r imary  a therectomy patcncy- -57  s tenoses :  DA on ly  g roup  (no  PTA)  
No. Interval Cumulative Standard 
Interval No. DA sites atherectomy Duration of Lost to Lost by patency patency rate error 
(mo.) at risk failures FlU ends FlU death rate (%) (%) 
0 1 57 1 0 0 0 0.98 1.00 0.0 
1-3 56 2 0 1 0 0.96 0.98 1.7 
4-6 53 3 5 0 0 0.94 0.95 3.0 
7-9 45 0 0 0 1 1.00 0.89 4.4 
10-12 44 1 6 3 0 0.97 0.89 4.4 
13-15 34 0 1 0 5 1.00 0.87 5.4 
16-18 28 1 1 1 0 0.96 0.87 6.0 
19-21 25 0 2 1 1 1.00 0.84 6.8 
22-24 21 0 1 0 0 1.00 0.84 7.4 
25-27 20 0 0 0 0 1.00 0.84 7.6 
28-30 20 0 3 0 0 1.00 0.84 7.6 
31-33 17 0 4 0 0 1.00 0.84 8.2 
34-36 13 0 2 0 0 1.00 0.84 9.4 
37-39 11 0 1 0 0 1.00 0.84 10.2 
40-42 10 0 0 1 0 1.00 0.84 10.7 
43-45 9 0 1 0 0 1.00 0.84 11.3 
46-48 8 0 4 0 2 1.00 0.84 12.0 
49-51 2 0 0 0 0 1.00 0.84 23.9 
52-54 2 0 0 0 0 1.00 0.84 23.9 
55-57 2 0 0 0 0 1.00 0.84 23.9 
58-60 2 0 0 0 0 1.00 0.84 23.9 
61-63 2 0 0 0 0 1.00 0.84 23.9 
64-66 2 0 2 0 0 1.00 0.84 23.9 
8* 7 
FlU, Follow-up. 
*One occlusion at 0 to 1 month,  one pseudoaneurysm at 3 months; and six restenoses. 
Append ix  C .  P r imary  a therectomy patency  44  gra f ts* :  combined  DA/PTA group  
No. Interval Cumulative 
Interval No. grafts atherectomy Duration of Lost to Lost by patency patency rate Standard error 
(too.) at risk failures FlU ends FlU death rate (%) (%) 
0-1 44 2 0 0 0 0.95 1.00 0.0 
1-3 42 3 0 2 0 0.93 0.95 3.1 
4-6 37 1 7 0 0 0.97 0.88 4.9 
7-9 29 0 2 0 1 1.00 0.86 6.0 
10-12 26 1 3 2 0 0.96 0.86 6.3 
13-15 20 0 0 0 1 1.00 0.82 7.8 
16-18 19 1 0 1 0 0.95 0.82 8.0 
19-21 17 0 1 1 0 1.00 0.78 8.9 
22 -24 15 0 1 0 0 1.00 0.78 9.5 
25-27 14 0 0 0 0 1.00 0.78 9.8 
28-30 14 0 3 0 0 1.00 0.78 9.8 
31-33 11 0 1 0 0 1.00 0.78 11.1 
34-36 10 0 2 0 0 1.00 0.78 11.6 
37-39 8 0 1 0 0 1.00 0.78 13.0 
40-42 7 0 0 1 0 1.00 0.78 13.9 
43-45 6 0 1 0 0 1.00 0.78 15.0 
46-48 5 0 2 0 1 1.00 0.78 16.4 
49-51 2 0 0 0 0 1.00 0.78 25.9 
52-54 2 0 0 0 0 1.00 0.78 25.9 
55-57 2 0 0 0 0 1.00 0.78 25.9 
58-60 2 0 0 0 0 1.00 0.78 25.9 
61-63 2 0 0 0 0 1.00 0.78 25.9 
64-66 2 0 1 0 0 1.00 0.78 25.9 
67-69 1 0 0 0 0 1.00 0.78 36.7 
70-72 1 0 0 0 0 1.00 0.78 36.7 
73-75 1 0 1 0 0 1.00 0.78 36.7 
81" 7 
F/U, Follow-up. 
*Thirty-five treated by DA only; eight PTA failures (>30% residual stenosis) followed by DA; one DA failure (>30% residual stenosis) 
followed by PTA. 
~Two occlusions at 0 to 1 month,  one pseudoaneurysm at 3 months, and five restenoses. 
JOURNAL OF VASCULAR SURGERY 
Volume 23, Number 4 Porter et al. 565 
Appendix D. Primary atherectomy patency--35 grafts: DA only group (no PTA) 
No. Interval Cumulative Standard 
Interval No. grafts atherectomy Duration of Lost to Lost by patency patency rate error 
(too.) at risk failures FlU ends FlU death rate (%) (%) 
O-1 35 1 0 0 0 0.97 1.O0 0.0 
1-3 34 2 0 ! 0 0.94 0.97 2.8 
4-6 31 1 6 0 0 0.96 0.91 4.8 
7-9 24 0 0 0 0 1.00 0.88 6.2 
10-12 24 1 3 2 0 0.95 0.88 6.2 
13-15 18 0 0 0 1 1.00 0.84 7.9 
16-18 17 1 0 1 0 0.94 0.84 8.2 
19-21 15 0 1 1 0 1.00 0.79 9.4 
22-24 13 0 1 0 0 1.00 0.79 10.1 
25-27 12 0 0 0 0 1.00 0.79 10.5 
28-30 12 0 2 0 0 1.00 0.79 10.5 
31-33 10 0 1 0 0 1.00 0.79 11.5 
34-36 9 0 2 0 0 1.00 0.79 12.1 
37-39 7 0 1 0 0 1.00 0.79 13.7 
40-42 6 0 0 1 0 1.00 0.79 14.8 
43-45 5 0 1 0 0 1.00 0.79 16.2 
46-48 4 0 2 0 1 1.00 0.79 18.1 
49-51 1 0 0 0 0 1.00 0.79 36.2 
52-54 1 0 0 0 0 1.00 0.79 36.2 
55-57 1 0 0 0 0 1.00 0.79 36.2 
58-60 1 0 0 0 0 1.00 0.79 36.2 
61-63 1 0 0 0 0 1.00 0.79 36.2 
64-66 1 0 1 _0 0 1.00 0.79 36.2 
6* 6 
FlU, Follow-up. 
*One occlusion at 0 to 1 month, 1 pseudoancurysm at 3 months, and fbur restenoses. 
Appendix E. Primary assisted atherectomy patency rates--44 grafts*: combined DA/PTA group 
Cumulative 
No. Interval patency Standard 
Interval No. grafts atherectom~, Duration of Lost to Lost by patency rate error 
(mo.) at risk failures FlU ends FlU death rate (%) (%) 
0 1 44 2 0 0 0 0.95 1.00 0.0 
1-3 42 3 0 2 0 0.93 0.95 3.1 
4 6 37 0 5 0 0 1.00 0.88 4.9 
7-9 32 1 1 0 1 0.97 0.88 5.3 
10-12 29 0 4 2 0 1.00 0.86 6.0 
13-15 23 0 0 0 1 1.00 0.86 6.8 
16-18 22 0 0 1 0 1.00 0.86 6.9 
19-21 21 0 0 1 1 1.00 0.86 7.1 
22-24 19 0 1 0 0 1.00 0.86 7.4 
25-27 18 0 1 0 0 1.00 0.86 7.7 
28-30 17 0 4 0 0 1.00 0.86 7.9 
31-33 13 0 1 0 0 1.00 0.86 9.0 
34-36 12 0 2 0 0 1.00 0.86 9.4 
37-39 10 0 1 0 0 1.00 0.86 10.3 
40-42 9 0 0 1 0 1.00 0.86 10.8 
43-45 8 0 1 0 0 1.00 0.86 11.5 
46-48 7 0 2 0 1 1.00 0.86 12.3 
49-51 4 0 1 0 0 1.00 0.86 16.2 
52 54 3 0 0 0 0 1.00 0.86 18.7 
55-57 3 0 0 0 0 1.00 0.86 18.7 
58-60 3 0 0 0 1 1.00 0.86 18.7 
61-63 2 0 0 0 0 1.00 0.86 23.0 
64-66 2 0 1 0 0 1.00 0.86 23.0 
67-69 i 0 0 0 0 1.00 0.86 32.5 
70-72 1 0 0 0 0 1.00 0.86 32.5 
73-75 1 0 1 0 0 1.00 0.86 32.5 
6J" 7 
FlU, Follow-up. 
*Initial graft atherectomy (combined DA/PTA) with added patency from three DA only for DA restenoses, four DA only fbr new stenoses, 
and one DA followed by PTA fbr a new stenosis. 
~'Two occlusions at 0 to 1 month, one pseudoancurysm at 3 months, and three restenoses. 
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Appendix F. Primary assisted atherectomy patency--35 grafts*: DA only group (no PTA) 
Cumulative 
No. Interval patency 
Interval No, grafts atherectomy Duration of Lost to Lost by patency rate 
(mo.) at risk failures FlU ends FlU death rate (%) 
Standard 
er ror  
(~) 
0-1 35 1 0 0 0 0.97 1.00 0.0 
1-3 34 2 0 1 0 0.94 0.97 2.8 
4-6 31 0 4 0 0 1.00 0.91 4.8 
7-9 27 1 0 0 0 0.96 0.91 5.2 
10-12 26 0 4 2 0 1.00 0.88 6.0 
13 15 20 0 0 0 1 1.00 0.88 6.8 
16-18 19 0 0 1 0 1.00 0.88 7.0 
19-21 18 0 1 1 1 1.00 0.88 7.2 
22-24 15 0 1 0 0 1.00 0.88 7.9 
25 27 14 0 0 0 0 1.00 0.88 8.2 
28-30 14 0 2 0 0 1.00 0.88 8.2 
31 33 12 0 1 0 0 1.00 0.88 8.8 
34-36 11 0 2 0 0 1.00 0.88 9.2 
37-39 9 0 1 0 0 1.00 0.88 10.2 
40-42 8 0 0 1 0 1.00 0.88 10.8 
43-45 7 0 1 0 0 1.00 0.88 11.5 
46-48 6 0 2 0 1 1.00 0.88 12.5 
49-51 3 0 1 0 0 1.00 0.88 17.6 
52-54 2 0 0 0 0 1.00 0.88 21.6 
55-57 2 0 0 0 0 1.00 0.88 21.6 
58-60 2 0 0 0 1 1.00 0.88 21.6 
61-63 1 0 0 0 0 1.00 0.88 30.5 
64-66 1 0 1 0 0 1.00 0.88 30.5 
4t 6 
FlU, Follow-up. 
*Initial graft DA only procedures with added patency from thrce DA only fbr DA restenoses and two DA only tbr new stenoses. 
i 'One occlusion at 0 to 1 month, one pseudoaneurysm at three months, and avo restenoses. 
Appendix G. Atherectomy extended graft patency: 44 grafts* combined DA/PTA group--total 
(primary and secondary) graf~ patency rates before atherectomy plus combined DA/PTA added 
patency rates 
Cumulative 
Interval patency Standard 
Interval No. grafts No. graft Duration of Lost to Lost by patency rate error 
(mo.) at risk failures FlU ends FlU deatl~ rate (%) (%) 
0-6 44 3 1 2 0 0.93 1.00 0.0 
7-12 38 0 0 0 0 1.00 0.93 4.0 
13-18 38 1 5 0 1 0.97 0.93 4.0 
19-24 31 1 1 4 1 0,96 0.90 5.1 
25-30 24 0 1 0 1 1,00 0.87 6.4 
31-36 22 0 4 0 0 1,00 0.87 6.7 
37-42 18 0 2 0 0 1.00 0.87 7.4 
43-48 16 0 2 1 0 1.00 0.87 7.8 
49-54 13 0 1 0 0 1.00 0.87 8.7 
55-60 12 0 1 0 1 1.00 0.87 9.0 
61-66 10 0 0 0 0 1.00 0 .87 9.9 
67-72 10 0 2 0 0 1.00 0.87 9.9 
73-78 8 0 1 0 1 1.00 0.87 11.1 
79-84 6 0 1 0 0 1.00 0.87 12.8 
85-90 5 0 1 0 0 1.00 0.87 14.0 
91-96 4 1 1 0 0 0.71 0.87 15.7 
97-102 2 0 0 0 0 1.00 0.62 27.0 
103-108 2 0 1 0 0 1.00 0.62 27.0 
109-114 1 0 1 0 0 1.00 0.62 38.2 
61 7 
FlU, Follow-up. 
* Initial graft procedures (35 DA only, 9 combined DA/PTA)  plus three 
one DA/PTA for a new stenosis. 
1-Two graft occlusions, one DA-site pseudoaneurysm, and three DA-site 
DA only for DA restenoses, four DA only for new stenoses, and 
restenoses. 
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Append ix  H .  Tota l  (p r imary  and  secondary)  g ra f t  patency  ra tes  be fore  a therectomy ~14 grafts  
combined  DA/PTA group  
Interval Cumulative 
patency patency 
Interval No. grafts No. graft Duration ~f Lost to Lost by rate rate 
(mo.) at risk failures FlU ends FlU death (%) (%) 
Standard 
error* 
(%) 
O- 1 44 0 0 0 0 1.00 1.00 0.0 
1-6 44 19 0 0 0 0.57 1.00 0.0 
7-12 25 8 0 0 0 0.68 0.57 7.5 
13-18 17 4 0 0 0 0.76 0.39 7.3 
19-24 13 3 0 0 0 0.77 0.30 6.9 
25-30 10 3 0 0 0 0.70 0.23 6.3 
31-36 7 2 0 0 0 0.71 0.16 5.5 
37-42 5 2 0 0 0 0.60 0.11 4.8 
43 48 3 0 0 0 0 ! .00 0.07 3.8 
49-54 3 0 0 0 0 1.00 0.07 3.8 
55 60 3 1 0 0 0 0.67 0.07 3.8 
61-66 2 0 0 0 0 1.00 0.05 3.1 
67-72 2 0 0 0 0 1.00 0.05 3.1 
73-78 2 1 0 0 0 0.50 0.05 3.1 
...-96 1 1 0 0 0 0.00 0.02 2.2 
FlU, Follow up. 
